BR112021000899A2 - Peptídeos de ligação a il-17a e usos médicos dos mesmos - Google Patents

Peptídeos de ligação a il-17a e usos médicos dos mesmos

Info

Publication number
BR112021000899A2
BR112021000899A2 BR112021000899A BR112021000899A BR112021000899A2 BR 112021000899 A2 BR112021000899 A2 BR 112021000899A2 BR 112021000899 A BR112021000899 A BR 112021000899A BR 112021000899 A BR112021000899 A BR 112021000899A BR 112021000899 A2 BR112021000899 A2 BR 112021000899A2
Authority
BR
Brazil
Prior art keywords
binding peptides
medical uses
medical
bioconjugates
dimers
Prior art date
Application number
BR112021000899A
Other languages
English (en)
Inventor
Andrea Aramini
Andrea Beccari
Flavio Mantelli
Marcello Allegretti
Marica Gemei
Original Assignee
Dompe Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farm Spa filed Critical Dompe Farm Spa
Publication of BR112021000899A2 publication Critical patent/BR112021000899A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

peptídeos de ligação a il-17a e usos médicos dos mesmos. a invenção refere-se a peptídeos de ligação a il-17a, inibidores da interação de il-17a com o receptor il-17ra, e a bioconjugados, dímeros, composições farmacêuticas e uso médico dos mesmos.
BR112021000899A 2018-07-27 2019-07-26 Peptídeos de ligação a il-17a e usos médicos dos mesmos BR112021000899A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18186029.7A EP3599245A1 (en) 2018-07-27 2018-07-27 Il-17a binding polypeptides and medical uses thereof
PCT/EP2019/070265 WO2020021103A1 (en) 2018-07-27 2019-07-26 Il-17a binding peptides and medical uses thereof

Publications (1)

Publication Number Publication Date
BR112021000899A2 true BR112021000899A2 (pt) 2022-04-12

Family

ID=63079805

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021000899A BR112021000899A2 (pt) 2018-07-27 2019-07-26 Peptídeos de ligação a il-17a e usos médicos dos mesmos

Country Status (11)

Country Link
US (2) US11236129B2 (pt)
EP (2) EP3599245A1 (pt)
JP (1) JP2021531309A (pt)
KR (1) KR20210038918A (pt)
CN (1) CN112513064A (pt)
AU (1) AU2019311304A1 (pt)
BR (1) BR112021000899A2 (pt)
CA (1) CA3106500A1 (pt)
IL (1) IL280407A (pt)
SG (1) SG11202100568WA (pt)
WO (1) WO2020021103A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210125601A (ko) 2019-03-06 2021-10-18 마이크론 테크놀로지, 인크 디지트 라인들 사이에 차폐 라인들을 갖는 집적 어셈블리, 및 집적 어셈블리 형성 방법
AR121959A1 (es) 2020-04-30 2022-07-27 Janssen Biotech Inc Imidazopiridazinas como moduladores de il-17
CN114751962B (zh) * 2022-03-17 2023-11-07 北京大学 订书肽、其制备方法及其制药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1983E (fr) 1902-06-23 1903-11-24 Georges Houdin Nouveau conduit de fumée, dit "wagon resserré"
US6515173B1 (en) * 2000-01-13 2003-02-04 Idun Pharmaceuticals, Inc. Inhibitors of the ICE/ced-3 family of cysteine proteases
US20070249533A1 (en) * 2005-09-28 2007-10-25 Levin Steven D Il-17a and il-17f antagonists and methods of using the same
TW201117824A (en) * 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
KR20170004011A (ko) * 2014-05-22 2017-01-10 피어이스 파마슈티컬즈 게엠베하 신규 특이적 결합 폴리펩타이드 및 이의 용도

Also Published As

Publication number Publication date
US20210300969A1 (en) 2021-09-30
CA3106500A1 (en) 2020-01-30
IL280407A (en) 2021-03-01
US11236129B2 (en) 2022-02-01
AU2019311304A1 (en) 2021-01-28
KR20210038918A (ko) 2021-04-08
EP3599245A1 (en) 2020-01-29
JP2021531309A (ja) 2021-11-18
WO2020021103A1 (en) 2020-01-30
EP3802563A1 (en) 2021-04-14
CN112513064A (zh) 2021-03-16
US20220112244A1 (en) 2022-04-14
SG11202100568WA (en) 2021-02-25

Similar Documents

Publication Publication Date Title
CY1123211T1 (el) Meθοδoi γia th θepaπeytikh antimetωπισh ή thn προληψη thς hmikpaniaς
CY1121025T1 (el) ΑΝΤΙΣΩΜΑ ANTI-cMET
BR112021024108A2 (pt) Inibidores de tead e usos dos mesmos
CL2019002134A1 (es) Composiciones terapéuticas inmunomoduladoras de arnm que codifican péptidos de activación de mutaciones oncogénicas.
BR112021024224A2 (pt) Inibidores de tead e usos dos mesmos
PH12019501824A1 (en) Anti-gprc5d antibody and molecule comprising the antibody
BR112018012164A2 (pt) anticorpos neutralizantes do vírus da imunodeficiência humana
BR112017025108A2 (pt) compostos seletivos de pyy e usos dos mesmos
BR112021000899A2 (pt) Peptídeos de ligação a il-17a e usos médicos dos mesmos
CY1123307T1 (el) Πρωτεϊνες συγχωνευσης fgf21 μακρας δρασης και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
BR112018008918A8 (pt) compostos de quimera proteólise dirigida e métodos para preparação e uso dos mesmos
EA202092032A1 (ru) Т-клеточный рецептор, специфичный в отношении ny-eso-1/lage-1, и его применения
EA202091342A3 (ru) Слитые белки интерлейкин-2/рецептор интерлейкина-2 альфа и способы применения
BR112021019748A2 (pt) Degradadores de stat e usos dos mesmos
BR112018075653A2 (pt) anticorpos anti-b7-h3 e conjugados anticorpo fármaco
CL2013000304A1 (es) Compuestos derivados de 2-arilamino-bencimidazoles inhibidores de prostaglandina e2 (mpges-1); composicion farmaceutica que los comprende; compuestos intermediarios; uso en el tratamiento de enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor.
CO6640289A2 (es) Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf)
EA201991207A1 (ru) Новые агонисты tnfr и их применение
EA202191806A1 (ru) Антитело против человеческого il-4ra и его применение
EA201690159A1 (ru) Способы и композиции для лечения рака
CY1123997T1 (el) Νεα μεταλλακτικη παραλλαγη αλβουμινης ανθρωπινου ορου
CO2016000671A1 (es) Construcciones de variantes de sirp-alfa y sus usos
DOP2017000246A (es) Polipéptidos dirigidos a la fusión de vih
CL2023000491A1 (es) Composiciones de erenumab y usos de las mismas (divisional de solicitud n° 02519-2020).
CL2021000129A1 (es) Apirasas solubilizadas, métodos y usos